Replacement Without Improvement

I have been using the same moisturiser for some years. Not out of brand loyalty in any considered sense, but because it worked—which is a criterion that sounds obvious until you observe how rarely it is treated as primary.

The product did what it was supposed to do without producing secondary effects that required management. The application was straightforward. The smell was not a factor because there was not much smell. This is, in the context of skincare products, a significant achievement, and one I had stopped noticing precisely because it was consistent.

The reformulation arrived without announcement. The product retained its name, its packaging, its position on the shelf, and its price. What changed was the formulation—the actual composition of the thing that was supposed to do the thing the product was for. I noticed the change through the secondary effects that the previous formulation had not produced. The smell was now a factor. The application produced a different result. The outcome was different in ways that were not improvements on the previous outcome and were, in some respects, reversals of it.

There was no information available to confirm that the reformulation had occurred. The product did not say new formula on the label, which is the convention when a change is believed to be an improvement and the manufacturer wants to draw attention to it. It did not say anything, which is the convention when the change has been made for reasons other than improved performance for the user—shelf life extension, ingredient substitution driven by cost or supply chain, compliance with new regulatory standards, branding refresh—and drawing attention to the change would invite the question of whether the change was an improvement.

The question of whether the change was an improvement from the user’s perspective had not, apparently, been the primary criterion driving the reformulation.

 

The pattern this represents is familiar in a different register from the one in which skincare products are usually discussed. It is the pattern of replacement without improvement—the substitution of one thing for another that is nominally the same, that occupies the same position in the user’s life and the market’s category, that retains the branding and the price point and the shelf location, while having drifted functionally from the purpose for which the original was valued.

The drift is not always in the direction of worse. Sometimes the reformulation genuinely improves the product for most users. Sometimes the regulatory compliance that drove the ingredient substitution produces a safer product even if a less effective one. Sometimes the shelf life extension that motivated the change makes the product available in markets where it was previously not viable. These are real goods, and they are real reasons for reformulation. The problem is not the reformulation. The problem is the absence of the information that would allow the user to understand what has changed and to assess whether the changed version serves their purpose.

The user who encounters a reformulated product without being told that the product has been reformulated is being managed rather than informed. The management is operationally sensible from the manufacturer’s perspective: informing users that the product has changed invites comparison, which invites the conclusion that the change was not an improvement, which invites the decision to find an alternative. Silence about the change avoids the invitation. The product continues to sell. The users who notice the change and whose use case is not served by the new formulation are an acceptable loss within the overall user population, whose majority may not notice or may not be affected.

The minority who notice and are affected have no recourse, because the product does not acknowledge the change and the information required to understand it is not available.

 

This is a small example of a large pattern, and it connects to the systems designed to address loneliness and isolation in a specific way. The services, the programmes, the referral pathways, the community groups, the befriending schemes—these are products in the sense that they are offerings designed to serve a purpose. They are evaluated, periodically reformed, updated in response to funding conditions, evidence reviews, regulatory requirements, and commissioning framework changes. The reform is typically presented as improvement—as a better-evidenced, more efficiently delivered, more appropriately targeted version of the thing the service was established to provide.

What is less consistently tracked is whether the reformed version serves the user’s actual purpose as well as the previous version did. The evidence review that drives the reform is typically a review of the evidence that the system can produce—the outcome measures, the scale scores, the participation rates, the cost-per-contact figures. The evidence it cannot easily produce—whether the reformed service is reaching the people the previous version reached, whether the changed referral pathway is accessible to the people who navigated the previous one, whether the updated group format is producing the quality of contact that the original produced—is not in the review, because it is not in the data that the system collects.

The service is nominally the same. The branding is the same. The position in the commissioning framework is the same. The specific quality of what it provides to the specific person who needs it may have drifted in ways that the evidence review did not detect, because the evidence review was measuring what the system could measure rather than whether the thing the system was for was being done.

 

The moisturiser problem and the loneliness service problem share a structural feature: the absence of the information that would allow the user to understand what they are encountering and whether it serves their purpose. The moisturiser does not say that the formulation has changed. The service does not say that the referral pathway has become more complex, that the group format has shifted from drop-in to pre-booked, that the service is now targeted at a different age group than the one it previously served, that the person who found it useful three years ago would find it less accessible today.

The user who encounters the changed service without being told that the service has changed is in the position of the person who bought the moisturiser expecting the formulation that had worked and found themselves using something different that was presented as the same thing. The problem is not the absence of a solution. The problem is the obstruction of access to the information that would allow the user to determine whether the available solution serves their purpose.

Many frustrations with systems designed to address isolation are not caused by the absence of solutions. They are caused by the unnecessary obstruction of access to information about whether the solutions that exist serve the purpose of the specific person seeking them. The referral pathway that does not explain who it is for. The service that does not say what it provides. The programme that does not say what has changed since the last time the user encountered it. The email with the broken link that presents three hundred characters of tracking parameters as a few easy steps.

Each of these is an obstruction that is not the absence of a solution. The solution may exist. The obstruction is between the person and the information that would allow them to determine whether the solution is for them.

 

The reformulation that optimises for shelf life, application ease, branding, or ingredient substitution more than core use is a reformulation that has placed operational considerations above user experience. This is not irrational from the manufacturer’s perspective. Shelf life matters for distribution. Application ease matters for the broader market. Branding matters for shelf presence. Ingredient substitution may be necessary for supply chain reasons that have nothing to do with the product’s performance. These are real considerations and they have real weight in the decisions that drive reformulation.

The weight they are given relative to the consideration of whether the reformulated product serves the purpose of the existing user is the question the reformulation process does not always ask with equivalent rigour. The existing user is one data point among many in the user population. The broader market is larger. The operational requirements are immediate.

The existing user’s experience of the reformulated product is a lagging indicator that arrives slowly, through complaints and returns and declining repurchase rates, by which time the reformulation has been in market long enough to be the established version rather than the new one.

The loneliness service that has been reformed to meet new commissioning requirements, or to satisfy an evidence review, or to expand its geographic reach, or to reduce its per-contact cost, has made decisions that are rational within the system’s operational logic. The existing user whose experience of the service has degraded because the reforms addressed operational requirements more directly than user experience is a lagging indicator that the system may not collect in a form that influences the next reform.

The service continues under the same name.

The referral pathway is different.

The group format has changed.

The imagined user has shifted.

The person who previously found it useful is navigating a reformulated product without having been told that the product has been reformulated.

 

Newer is not the same as better. This observation sounds obvious and is consistently underweighted in the decisions that drive reformulation, because the people making those decisions are operating within a logic that treats change as progress unless evidence to the contrary is available, and the evidence to the contrary is the kind that arrives slowly and is not in the data that the system collects in real time.

The person who found the previous version useful and finds the reformed version less useful is not in the evidence review. They are not in the outcome data, because they are no longer using the service. They are in the non-click statistics, the lapsed-user cohort, the people who were reached by the broken-link email and could not follow the few easy steps to re-engage.

The system has their data.

It has the tracking parameters.

It knows they did not click.

It does not know why.

The product is on the shelf.

The label says what it has always said.

The formulation is different.